Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03403205
Brief Title: Efficacy and Safety of ALXN1840 (Formerly Named WTX101) Administered for 48 Weeks Versus Standard of Care in Patients With Wilson Disease With an Extension Period of up to 60 Months

First Submitted : December 19, 2017
First Submitted that Met QC Criteria : January 10, 2018
First Posted : January 18, 2018

Last Update Submitted that Met QC Criteria : April 6, 2020
Last Update Posted : April 7, 2020